Enfusion inc (ENFN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ENFN Annual Balance Sheets →
Balance sheet data covering Enfusion inc–Dec 31 2023 offers a view into how Dec 31 2024's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent54.48
Cash & Short-term Investments54.00
Accounts receivable31.99
Other Current Assets1.71
Prepaid Expense, Current AS5.34
Total Current Assets93.52
Equipment/Property/Plant Net20.96
Other Assets, Noncurrent12.00
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent3.00
Operating Lease Right Of Use Asset18.06
Total Assets143.26
Liabilities
Accounts Payable, Current AC0.87
Other Liabilities, Current26.47
Total Current Liabilities27.34
Total Long-term Debt0.00
Other liabilities, Noncurrent16.39
Accrued Expenses And Other Liabilities Current20.39
Operating Lease Liability Noncurrent14.24
Total Liabilities43.72
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock243.94
Retained Earnings / Accumulated Deficit-170.11
Other Equity-0.70
Common Stockholder's Equity73.22
Non-controlling interests & other26.32
Total Stockholder's Equity99.54
Liabilities & Stockholder's Equity143.26
4 historic quarters locked

Sign in to unlock the full Enfusion inc balance sheet history.

About Enfusion Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-24-014265

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.